AJG
- NYSE - INSURANCE - Insurance Brokers
Gallagher Arthur J & Co
|
$76.28 |
-0.79 -1.03%
|
$78.33
|
$79.03
|
-3.48% |
746,111 73.58%
|
1,014,000
|
Most Recent Note for AJG - 12/3/2018 12:12:01 PM
Perched near its all-time high. The 10/23/18 mid-day report last noted - "Quarterly earnings increases have not been strong and steady above the +25% minimum guideline (C criteria). Insurance firm's annual earnings (A criteria) history has been steady."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BA
- NYSE - AEROSPACE/DEFENSE - Aerospace/Defense - Major
Boeing Co
|
$358.85 |
+12.09
3.49%
|
$369.00
|
$394.28
|
-8.99% |
3,873,588 93.79%
|
4,130,000
|
Most Recent Note for BA - 12/3/2018 12:13:17 PM
Rebounding above both its 50 and 200 DMA lines with today's big gap up gain. Prior mid-day reports cautioned members - "The 4 latest quarterly comparisons showed strong earning increases, and it reported earnings +37% on +4% sales revenues for the Sep '18 quarter. Sub par sales revenues growth rate and the prior earnings history has not been a great match with the guidelines (A criteria) of the fact-based investment system."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BEAT
- NASDAQ - Medical-Services
BioTelemetry Inc
|
$71.74 |
+0.80
1.13%
|
$74.73
|
$72.94
|
-1.65% |
406,250 72.80%
|
558,000
|
Most Recent Note for BEAT - 12/3/2018 12:13:56 PM
Rallying to new 52-week and all-time highs with today's 8th consecutive gain. It did not form a sound base pattern. Patient investors may watch for a new base or secondary buy point to possibly develop and be noted in the weeks ahead. Showed solid sales revenues growth and earnings increases were well above the +25% minimum guideline (C criteria) in the 4 latest quarterly comparisons through Sep '18 versus the year ago periods, helping it better match the fact-based investment system's winning models.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
BSTC
- NASDAQ - Medical-Biomed/Biotech
Biospecifics Technologie
|
$61.55 |
+0.18
0.29%
|
$64.11
|
$66.21
|
-7.04% |
26,203 72.79%
|
36,000
|
Most Recent Note for BSTC - 12/3/2018 12:15:20 PM
Rebounding above its 50 DMA line toward its 52-week high. Noted with caution in prior mid-day reports - "Fundamental concerns remain. Earnings increases have not been strong and steady above the +25% minimum guideline (C criteria) in quarterly comparisons."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CAE
- NYSE - MANUFACTURING - Farm & Construction Machinery
C A E Inc
|
$20.36 |
+0.07
0.34%
|
$20.73
|
$21.70
|
-6.18% |
126,597 73.18%
|
173,000
|
Most Recent Note for CAE - 12/3/2018 12:16:40 PM
The 11/26/18 mid-day report last cautioned members - "Reported earnings +15% on +20% sales revenues for the Sep '18 quarter. Prior quarterly and annual earnings (C and A criteria) history remains below the guidelines of the fact-based investment system."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
CVGW
- NASDAQ - FOOD & BEVERAGE - Farm Products
Calavo Growers Inc
|
$94.09 |
-4.20 -4.27%
|
$99.06
|
$108.00
|
-12.88% |
102,464 90.68%
|
113,000
|
Most Recent Note for CVGW - 12/3/2018 12:19:31 PM
Violating its 200 DMA line with today's big loss testing prior lows in the $91-92 area. Last noted with caution in the 11/16/18 mid-day report - "Reported earnings +72% on -2% sales revenues for the quarter ended July 31, 2018 versus the year ago period. Fundamental concerns remain. Quarterly sales revenues and earnings history has not been steady, and its up and down annual earnings (A criteria) history is a concern. Increasing ownership by top-rated funds (I criteria) is a reassuring sign."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
DATA
- NYSE - HEALTH SERVICES - Medical Laboratories & Researc
Tableau Software Cl A
|
$126.17 |
+1.53
1.23%
|
$127.49
|
$125.50
|
0.53% |
753,682 72.68%
|
1,037,000
|
Most Recent Note for DATA - 12/3/2018 12:22:40 PM
Hitting a new 52-week high with today's 4th consecutive gain. The 11/21/18 mid-day report last noted - "Found support at its 200 DMA line during the prior consolidation. Reported earnings +488% on +35% sales revenues for the Sep '18 quarter, its 3rd strong quarter. Fundamental concerns remain because its annual earnings (A criteria) history has not been strong and steady."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
ECOL
- NASDAQ - MATERIALS & CONSTRUCTION - Waste Management
U S Ecology Inc
|
$68.14 |
-1.53 -2.20%
|
$70.00
|
$77.15
|
-11.68% |
60,373 67.83%
|
89,000
|
Most Recent Note for ECOL - 12/3/2018 12:27:37 PM
Meeting resistance at its 50 DMA line in recent weeks. Noted with caution in prior mid-day reports - "Reported a 3rd consecutive quarter above the +25% minimum earnings guideline (C criteria) in Jun '18. Annual earnings (A criteria) history has been up and down, not strong and steady."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
EL
- NYSE - CONSUMER NON-DURABLES - Personal Products
Estee Lauder Cos Cl A
|
$150.95 |
+8.29
5.81%
|
$151.10
|
$158.80
|
-4.94% |
1,794,665 78.82%
|
2,277,000
|
Most Recent Note for EL - 12/3/2018 12:31:00 PM
Rallying well above its 50 DMA line and nearly challenging its 52-week high with today's big gain. Reported earnings +24% on +8% sales revenues for the Sep '18 quarter. Last noted in the 8/19/15 mid-day report-"Prior quarterly comparisons were not a match with the investment system's fundamental guidelines. Quarterly earnings results and sales revenues increases do not solidly meet the fact-based system's guidelines and its annual earnings (A criteria) history has been up and down."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
ESRX
- NASDAQ - HEALTH SERVICES - Specialized Health Services
Express Scripts Hldg Co
|
$100.14 |
-1.33 -1.31%
|
$101.73
|
$101.71
|
-1.54% |
2,652,002 71.46%
|
3,711,000
|
Most Recent Note for ESRX - 12/3/2018 12:32:49 PM
Perched at its 52-week high following a streak of gains. The 11/26/18 mid-day report noted - "Found prompt support near its 50 DMA line in recent months. Reported earnings +28% on +4% sales revenues for the Sep '18 quarter. Earnings growth has been above the +25% minimum guideline (C criteria) in the 3 latest comparisons, but with sub par sales revenues growth, so fundamental concerns remain. Total shares outstanding of 563.9 million makes it an unlikely sprinter. It has maintained a steady annual earnings history (A criteria)."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
GIII
- NASDAQ - CONSUMER NON-DURABLES - Textile - Apparel Footwear
G Iii Apparel Group Inc
|
$43.71 |
+3.63
9.06%
|
$44.36
|
$51.20
|
-14.63% |
626,917 94.27%
|
665,000
|
Most Recent Note for GIII - 12/3/2018 12:34:13 PM
Rebounding above its 50 and 200 DMA lines with today's big gain. Last noted with caution in the 9/11/18 mid-day report - "Reported earnings of 22 cents per share on +16% sales revenues versus a loss of 18 cents per share for the year ago period ended April 30th. Fundamental concerns remain. Shares split 2:1 effective 5/04/15. Earnings history has not been a good match with the guidelines of the fact-based investment system. Completed a new Public Offering on 6/24/14."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MA
- NYSE - Finance-CrdtCard/PmtPr
Mastercard Inc Cl A
|
$209.37 |
+8.30
4.13%
|
$209.62
|
$225.35
|
-7.09% |
3,177,865 66.51%
|
4,778,000
|
Most Recent Note for MA - 12/3/2018 12:39:39 PM
Gapped up today rebounding above its 50 DMA line ($203) helping its outlook to improve, however, it faces near-term resistance due to overhead supply up to the $225 level. Undercut its 200 DMA line during the consolidation after dropped from the Featured Stocks list on 10/24/18.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
MKTX
- NASDAQ - FINANCIAL SERVICES - Investment Brokerage - Nationa
Marketaxess Holdings Inc
|
$216.12 |
-1.61 -0.74%
|
$218.77
|
$229.84
|
-5.97% |
168,679 70.28%
|
240,000
|
Most Recent Note for MKTX - 12/3/2018 1:04:48 PM
Perched within striking distance of its 52-week and all-time highs. Reported earnings +18% on +6% sales revenues for the Sep '18 quarter. Prior quarterly comparisons were also below the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) growth has been strong.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
NXST
- NASDAQ - MEDIA - Broadcasting - TV
Nexstar Broadcasting Grp
|
$84.53 |
+1.89
2.29%
|
$85.78
|
$89.75
|
-5.82% |
1,246,593 214.19%
|
582,000
|
Most Recent Note for NXST - 12/3/2018 1:06:59 PM
Found prompt support near its 200 DMA line and now challenging its 52-week high with today's 8th consecutive gain. Recent quarterly comparisons through Sep '18 showed strong earnings increases above the +25% minimum guideline (C criteria) versus the year ago periods, however, prior sequential comparisons showed worrisome deceleration in its sales revenues growth. Completed Secondary Offerings on 11/29/12 and 2/08/13.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
PKI
- NYSE - Medical-Research Eqp/Svc
Perkinelmer Inc
|
$89.55 |
+2.49
2.86%
|
$91.00
|
$98.33
|
-8.93% |
780,428 110.39%
|
707,000
|
Most Recent Note for PKI - 12/3/2018 1:09:42 PM
Rebounding above its 50 DMA line ($87) with today's gap up and 9th consecutive gain with ever-increasing volume. Reported earnings +23% on +22% sales revenues for the Sep '18 quarter, and fundamental concerns remain. Quarterly and annual earnings (C and A criteria) history is not good match with the fact-based system's guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
REGN
- NASDAQ - DRUGS - Biotechnology
Regeneron Pharmaceutical
|
$389.53 |
+23.88
6.53%
|
$394.98
|
$416.49
|
-6.47% |
496,350 68.18%
|
728,000
|
Most Recent Note for REGN - 12/3/2018 1:19:52 PM
Gapped up today and rebounded above its 50 DMA line. Faces additional overhead supply to act as resistance. Reported earnings +47% on +11% sales revenues for the Sep '18 quarter, its 6th consecutive quarter above the +25% minimum guideline (C criteria). Downturn in FY '15 earnings was a flaw in its annual earnings (A criteria) history.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SODA
- NASDAQ - CONSUMER DURABLES - Appliances
Sodastream Intl Ltd
|
$143.68 |
+0.03
0.02%
|
$143.85
|
$143.84
|
-0.11% |
293,162 117.26%
|
250,000
|
Most Recent Note for SODA - 12/3/2018 1:20:25 PM
This Israeli maker of home beverage carbonation systems held its ground in a tight range with volume totals cooling since a big gap up on 8/20/18 M&A news with Pepsico Inc (PEP) capped an impressive streak of gains marked by heavy volume. Reported earnings +78% on +31% sales revenues for the Jun '18 quarter, and 3 of the past 4 quarterly comparisons were above the +25% minimum guideline (C criteria). Up and down annual earnings history (A criteria) was noted as not a great match with the fact-based investment system's fundamental guidelines.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
SVBI
- NASDAQ - Finance-Savings & Loan
Severn Bancorp Inc (Md)
|
$9.00 |
-0.05 -0.52%
|
$9.10
|
$9.86
|
-8.70% |
12,902 117.29%
|
11,000
|
Most Recent Note for SVBI - 12/3/2018 1:21:24 PM
This thinly-traded Finance - Savings & Loan firm rebounded above its 50 DMA line last week with gains after finding support near its 200 DMA line. Earnings increases in recent quarterly comparisons through Sep '18 have been above the +25% minimum guideline (C criteria) with strong sales revenues growth. Prior mid-day reports cautioned - "Up and down annual earnings (A criteria) history is not a match with the fact-based investment system's fundamental guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
VMW
- NYSE - COMPUTER SOFTWARE & SERVICES - Technical & System Software
Vmware Inc Cl A
|
$162.02 |
-5.32 -3.18%
|
$168.89
|
$168.42
|
-3.80% |
1,071,003 83.09%
|
1,289,000
|
Most Recent Note for VMW - 12/3/2018 1:24:15 PM
Reversed today after hitting a new all-time high, pulling back following 3 consecutive volume-driven gains. Reported earnings +27% on +14% sales for the Oct '18 quarter, but prior quarters were below the +25% minimum guideline (C criteria). It was dropped from the Featured Stocks list on 5/14/12.
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|
VZ
- NYSE - TELECOMMUNICATIONS - Telecom Services - Domestic
Verizon Communications
|
$58.19 |
-2.11 -3.50%
|
$59.75
|
$61.58
|
-5.51% |
12,743,233 69.28%
|
18,394,000
|
Most Recent Note for VZ - 12/3/2018 1:26:01 PM
Retreating in recent weeks after rallying within close striking distance of its all time high ($62.27 in Oct 1999). The 11/20/18 mid-day report last noted - "Reported earnings +24% on +3% sales revenues for the Sep '18 quarter. Sales revenues growth has been sub par while its quarterly and annual earnings history (C and A criteria) is not a match with the fact-based investment system's guidelines."
|
View all notes |
Alert me of new notes |
Company Profile |
SEC |
News |
Chart | C
A N
S L
I M
|